Holdings (Monthly)
Guide ↗
Select Health Care Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UCB SA | N/A | Feb 2026 | 400,000 | NEW | $117.4M | — | 2.03% | EC |
| 2 | NATERA INC | 632307104 | May 2026 | 328,000 | NEW | $73.3M | — | 1.27% | EC |
| 3 | VIATRIS INC | 92556V106 | May 2026 | 4,280,000 | NEW | $69.6M | — | 1.20% | EC |
| 4 | WEST PHARMACEUTICAL SVCS INC | 955306105 | May 2026 | 200,000 | NEW | $64.6M | — | 1.12% | EC |
| 5 | AGILENT TECHNOLOGIES INC | 00846U101 | May 2026 | 470,800 | NEW | $63.8M | — | 1.10% | EC |
| 6 | ROYALTY PHARMA PLC | N/A | Feb 2026 | 1,120,000 | NEW | $62.5M | — | 1.08% | EC |
| 7 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 235,000 | NEW | $55.6M | — | 0.96% | EC |
| 8 | ROCHE HOLDING AG | N/A | Feb 2026 | 128,000 | NEW | $54.0M | — | 0.93% | EC |
| 9 | BRUKER CORP | 116794108 | May 2026 | 850,000 | NEW | $50.1M | — | 0.87% | EC |
| 10 | ELEVANCE HEALTH INC | 036752103 | May 2026 | 110,000 | NEW | $43.3M | — | 0.75% | EC |
| 11 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 844,907 | NEW | $40.9M | — | 0.71% | EC |
| 12 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,280,000 | NEW | $38.4M | — | 0.66% | EC |
| 13 | SARTORIUS STEDIM BIOTECH | N/A | Feb 2026 | 128,000 | NEW | $26.6M | — | 0.46% | EC |
| 14 | PHARVARIS BV | N/A | Feb 2026 | 800,000 | NEW | $24.1M | — | 0.42% | EC |
| 15 | RELAY THERAPEUTICS INC | 75943R102 | May 2026 | 1,680,000 | NEW | $23.6M | — | 0.41% | EC |
| 16 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 690,000 | NEW | $23.2M | — | 0.40% | EC |
| 17 | IRHYTHM TECHNOLOGIES INC | 450056106 | May 2026 | 180,000 | NEW | $20.5M | — | 0.35% | EC |
| 18 | DIANTHUS THERAPEUTICS INC | 252828108 | May 2026 | 207,448 | NEW | $19.3M | — | 0.33% | EC |
| 19 | KESTRA MEDICAL TECHNOLOGIES INC | N/A | Feb 2026 | 900,000 | NEW | $19.1M | — | 0.33% | EC |
| 20 | VERADERMICS INC | 922967104 | May 2026 | 180,000 | NEW | $18.2M | — | 0.31% | EC |
| 21 | CLEERLY INC | N/A | Feb 2026 | 1,285,367 | NEW | $15.5M | — | 0.27% | EP |
| 22 | 10X GENOMICS INC | N/A | Feb 2026 | 500,000 | NEW | $14.2M | — | 0.24% | EC |
| 23 | GMR SOLUTIONS INC | 38013D106 | May 2026 | 993,539 | NEW | $12.4M | — | 0.21% | EC |
| 24 | CANDID THERAPEUTICS | N/A | Feb 2026 | 3,162,302 | NEW | $11.7M | — | 0.20% | EP |
| 25 | EDGEWISE THERAPEUTICS INC | 28036F105 | May 2026 | 294,000 | NEW | $10.0M | — | 0.17% | EC |
| 26 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 316,310 | NEW | $9.7M | — | 0.17% | EP |
| 27 | TYRA BIOSCIENCES INC | 90240B106 | May 2026 | 280,000 | NEW | $9.4M | — | 0.16% | EC |
| 28 | ENDEAVOR BIOMEDICINES INC | N/A | Feb 2026 | 1,366,212 | NEW | $8.9M | — | 0.15% | EP |
| 29 | KARDIUM INC/US | N/A | Feb 2026 | 15,888,877 | NEW | $8.3M | — | 0.14% | EP |
| 30 | INSIGHTEC LTD | N/A | Feb 2026 | 11,853,768 | NEW | $8.2M | — | 0.14% | EP |
| 31 | ALUMIS INC | 022307102 | May 2026 | 301,364 | NEW | $6.5M | — | 0.11% | EC |
| 32 | ALEDADE INC | N/A | Feb 2026 | 201,220 | NEW | $6.5M | — | 0.11% | EP |
| 33 | FIRST TRACKS BIOTHERAPEUTICS INC | 337185102 | May 2026 | 400,000 | NEW | $6.4M | — | 0.11% | EC |
| 34 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 572,265 | NEW | $6.3M | — | 0.11% | EP |
| 35 | ALMAR BIOSCIENCES INC | 010911105 | May 2026 | 300,000 | NEW | $6.1M | — | 0.11% | EC |
| 36 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 869,000 | NEW | $6.0M | — | 0.10% | EP |
| 37 | CELLCENTRIC LTD | N/A | Feb 2026 | 1,214,928 | NEW | $5.8M | — | 0.10% | EP |
| 38 | KARDIUM INC/US | N/A | Feb 2026 | 4,095,710 | NEW | $4.4M | — | 0.08% | DBT |
| 39 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 8,252,708 | NEW | $3.9M | — | 0.07% | EP |
| 40 | MANUS BIO INC | N/A | Feb 2026 | 1,079,396 | NEW | $3.6M | — | 0.06% | EP |
| 41 | PERCEPTIVE CAPITAL SOLUTIONS CORP | N/A | Feb 2026 | 320,567 | NEW | $3.2M | — | 0.06% | EC |
| 42 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | NEW | $3.1M | — | 0.05% | EP |
| 43 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | NEW | $3.1M | — | 0.05% | EP |
| 44 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 160,865 | NEW | $3.0M | — | 0.05% | EC |
| 45 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 3,696,429 | NEW | $2.8M | — | 0.05% | EP |
| 46 | ASIMOV INC | N/A | Feb 2026 | 101,438 | NEW | $2.5M | — | 0.04% | EP |
| 47 | WUGEN INC | N/A | Feb 2026 | 2,299,153 | NEW | $2.4M | — | 0.04% | DBT |
| 48 | HEAL THRIVE HOLDINGS LLC | N/A | Feb 2026 | 473,270 | NEW | $2.3M | — | 0.04% | EC |
| 49 | DMED BIOPHARMACEUTICAL CO LTD | N/A | Feb 2026 | 330,316 | NEW | $2.3M | — | 0.04% | EP |
| 50 | HEMAB THERAPEUTICS HOLDINGS INC | 423494103 | May 2026 | 65,000 | NEW | $1.9M | — | 0.03% | EC |
| 51 | ALEDADE INC | N/A | Feb 2026 | 56,664 | NEW | $1.8M | — | 0.03% | EP |
| 52 | KARDIUM INC/US | N/A | Feb 2026 | 3,477,566 | NEW | $1.8M | — | 0.03% | EP |
| 53 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 1,035,085 | NEW | $1.4M | — | 0.02% | DBT |
| 54 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $1.3M | — | 0.02% | EC |
| 55 | SALUDA MEDICAL INC | N/A | Feb 2026 | 338,168 | NEW | $875K | — | 0.02% | EC |
| 56 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $865K | — | 0.01% | EC |
| 57 | WUGEN INC | N/A | Feb 2026 | 454,342 | NEW | $704K | — | 0.01% | EP |
| 58 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 275,300 | NEW | $702K | — | 0.01% | EC |
| 59 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $685K | — | 0.01% | EC |
| 60 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $588K | — | 0.01% | EC |
| 61 | INMED PHARMACEUTICALS INC | N/A | Feb 2026 | 206,100 | NEW | $476K | — | 0.01% | EC |
| 62 | ELEVATEBIO, LLC | N/A | Feb 2026 | 254,900 | NEW | $469K | — | 0.01% | EP |
| 63 | SALUDA MEDICAL INC | N/A | Feb 2026 | 1,600,000 | NEW | $414K | — | 0.01% | EC |
| 64 | KARDIUM INC/US | N/A | Feb 2026 | 723,517 | NEW | $376K | — | 0.01% | EP |
| 65 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $361K | — | 0.01% | EC |
| 66 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $352K | — | 0.01% | EC |
| 67 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 15,815 | NEW | $173K | — | 0.00% | EC |
| 68 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $115K | — | 0.00% | EC |
| 69 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $57K | — | 0.00% | EC |
| 70 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $57K | — | 0.00% | EC |
| 71 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $43K | — | 0.00% | EC |
| 72 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $27K | — | 0.00% | EC |
| 73 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $26K | — | 0.00% | EC |
| 74 | CYCLERION THERAPEUTICS INC | 23255M204 | May 2026 | 3,000 | NEW | $9K | — | 0.00% | EC |
| 75 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $246 | — | 0.00% | EC |